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A B S T R A C T
Lack of evidence about the external validity of Discrete Choice Experiments (DCEs)-sourced preferences inhibits
greater use of DCEs in healthcare decision-making. This study examines the external validity of such preferences,
unravels its determinants, and provides evidence of whether healthcare choice is predictable. We focused on in-
fluenza vaccination and used a six-step approach: i) literature study, ii) expert interviews, iii) focus groups, iv) survey
including a DCE, v) field data, and vi) in-depth interviews with respondents who showed discordance between stated
choices and actual healthcare utilization. Respondents without missing values in the survey and the actual healthcare
utilization (377/499 = 76%) were included in the analyses. Random-utility-maximization and random-regret-
minimization models were used to analyze the DCE data, whereas the in-depth interviews combined five scientific
theories to explain discordance. When models took into account both scale and preference heterogeneity, real-world
choices to opt for influenza vaccination were correctly predicted by DCE at an aggregate level, and 91% of choices
were correctly predicted at an individual level. There was 13% (49/377) discordance between stated choices and
actual healthcare utilization. In-depth interviews showed that several dimensions played a role in clarifying this
discordance: attitude, social support, action of planning, barriers, and intention. Evidence was found that our DCE
yields accurate actual healthcare choice predictions if at least scale and preference heterogeneity are taken into
account. Analysis of discordant subjects showed that we can even do better. The DCE measures an important part of
preferences by focusing on attribute tradeoffs that people make in their decision to participate in a healthcare
intervention. Inhibitors may be among these attributes, but it is more likely that inhibitors have to do with exogenous
factors like goals, religion, and social norms. Con-ducting upfront work on constraints/inhibitors of the focal be-
havior, not just what promotes the behavior, might further improve predictive ability.
1. Introduction
Discrete choice experiments (DCEs) have been introduced in health
economics to elicit preferences for health and healthcare (Ryan, 2004).
The DCE technique is mainstream in marketing, transport, and en-
vironmental economics, where it is used to predict individual and col-
lective choices and calculate willingness-to-pay measures (Bliemer and
Rose, 2011; Mahieu et al., 2017). Over the last two decades, the DCE
application in health economics has grown exponentially as this
method for collecting choice data is relatively easy to apply, appears
efficient, and the analysis of the data is able to address a wide range of
important questions for regulators, industry, health technology assess-
ment bodies, and patient organizations (de Bekker-Grob et al., 2012;
Clark et al., 2014; Soekhai et al., 2019; Rowen et al., 2018; de Bekker-
Grob et al., 2008, 2010; Kohler et al., 2015). Among other topics, DCEs
in health economics are used for valuing and investigating trade-offs
between health and non-health outcomes, developing priority setting
frameworks, and predicting uptake for where there is no information or
trial data (Soekhai et al., 2019). However, the lack of evidence about
the external validity of DCEs is one of the barriers that inhibits greater
use of DCEs in healthcare decision-making.
The external validity of DCEs is concerned with ensuring the com-
parability of hypothetical (stated) choices and actual (revealed) choices
(Quaife et al., 2018). To support claims based on DCEs for healthcare
decision-making, there is a great need for research on the external va-
lidity of DCEs, particularly empirical studies assessing predicted and
revealed preferences of a representative sample of participants (Quaife
et al., 2018). Although a DCE succeeds in demonstrating internal va-
lidity (e.g., how accurately preferences are measured; the extent to
which the results are consistent with a priori expectations; and the
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extent to which the DCE takes account of all things deemed important
in the construct's domain (Janssen et al., 2017; Cheraghi-Sohi et al.,
2008; Determann et al., 2016; Ryan et al., 2001), this does not guar-
antee external validity (Ryan et al., 2001; Luce et al., 1999; Watson
et al., 2009).
The studies, mainly outside healthcare, that have investigated the
external validity of DCEs (Adamowicz et al., 1994; Kesternich et al.,
2013; Mueller et al., 2010; Mark and Swait, 2004; Cameron et al., 2002;
Carlsson and Martinsson, 2001; Fifer et al., 2014; Natter and Feurstein,
2002), all focus on final outcomes only (Lancsar and Swait, 2014).
However, the investigation of the external validity should be much
broader (Lancsar and Swait, 2014). That is, we need to know where
exactly discrepancies arise when stated choices derived from DCE do
not match actual healthcare utilization. Identifying the determinants of
DCE the external validity is crucial to obtain predictions with the
greatest accuracy (Quaife et al., 2018), and as such, to be valuable to
healthcare decision-making. The aim of this study is to measure the
external validity of predictions based on stated choices, unravel its
determinants, and provide some evidence about whether healthcare
choice is predictable.
2. Methods
For several reasons we focused on the field of influenza vaccination
for persons 60≤ years of age: (a) subjects face a real choice since they
are not obliged to opt for vaccination, which is vital to test the con-
sistency between stated and actual healthcare choices; (b) the number
of people facing this decision is large, contributing to the relevance and
feasibility of the study; and (c) logistic reasons since we had access to
actual influenza vaccination choice data on an individual level, which is
crucial to detect individuals who show discordance between stated
choices and actual healthcare utilization. A mixed methods approach
was used, which included six steps: i) a literature study, ii) expert in-
terviews, iii) focus groups, iv) a survey including a DCE, v) field data,
and vi) in-depth interviews. A within-sample design was used (i.e., the
same respondents were involved in the survey, in the field data as well
as in the in-depth interviews of our study) combining techniques from
econometrics, medical and behavioral research. Approval for the study
was obtained from the Medical Ethics Committee, Erasmus MC (MEC-
2016-095).
2.1. Literature study, expert interviews, and focus groups
We used a literature search (Sadique et al., 2013; Determann et al.,
2014; Shono and Kondo, 2014; Goodwin et al., 2006; Burns et al.,
2005), interviews with experts in the field of influenza vaccination
(n = 4) and three focus groups with patients aged 60 years and older
from two Dutch general practices from urban and rural areas (n = 21;
i.e., the target group) to develop and operationalize influenza vacci-
nation attributes. During this qualitative work, the nominal group
technique (Delbecq and Van de Ven, 1971) was applied to detect the
most relevant influenza vaccination attributes to be included in the
DCE: vaccination effectiveness, risk of severe side effects, risk of mild
side effects, protection duration, and incubation time (Table 1) (de
Bekker-Grob et al., 2018). The levels for each attribute incorporated the
range of possible vaccination outcomes based on current literature and
near future or plausible expectations (Table 1). The levels of the ef-
fectiveness attribute (i.e., 20%, 40%, 60%, and 80%) were explained as
follow: “Suppose that all 100 people had the flu vaccination, the
number of people who get the flu depends on the effectiveness of the flu
vaccination. The effectiveness differs per flu vaccination and may, for
example, have the following level: 80%. This means that of all 100
people who would get the flu, 80 people will NOT get the flu anymore,
while 20 people will still get the flu”. Noteworthy, in the Netherlands,
recipients of 60 years and older (our target population) do not have to
pay for influenza vaccination.
2.2. Discrete choice experiment (DCE)
The combination of five attributes with two, three and four levels
each results in 216 (21 × 33 x 41) potential influenza vaccination
profiles, and in 23,220 (i.e., 216 x 215 x 0.5) unique paired compar-
isons of influenza vaccination scenarios (i.e., choice tasks). To create a
much smaller subset of choice tasks with little loss of information or
estimation precision, while accommodating substantial respondent
hetero-geneity, a Bayesian D-efficient heterogeneous DCE design was
used (Sándor and Wedel, 2005). We generated a heterogeneous DCE
design consisting of 10 sub-designs using Fortran language. Together
these sub-designs were optimal to estimate a multinomial logit model,
based on a main-effects utility function including 2-way interactions
between the attribute ‘effectiveness’ and the other attributes. The prior
preference information (attribute weights) as required for the Bayesian
efficient optimization approach was obtained from best guess priors
using expert judgement, and updated after a pilot run of 100 re-
spondents. Each respondent was assigned randomly to a sub-design
containing 16 discrete choice tasks each.
The DCE design contained three alternatives for each choice task
(i.e., two flu vaccine alternatives and one ‘no flu vaccine’) (see Fig. 1 for
an example). Although presenting a choice task with two alternatives
(i.e., one flu vaccine alternative and one ‘no flu vaccine’ alternative) is a
better reflection of the actual decision for influenza vaccination, pre-
vious research showed that DCE models seem to be better able to pre-
dict choices and performed best when three alternatives instead of two
alternatives are presented to respondents (de Bekker-Grob et al., 2019).
Further, showing two flu vaccine alternatives ensures that for re-
spondents who always get vaccinated we still capture their trade-offs
with respect to the underlying attributes. The ‘opt out’ (i.e., no flu
vaccine) alternative was necessary as influenza vaccination is a pre-
ventive intervention and, as in real life, respondents are not obliged to
get vaccinated against influenza.
2.3. Survey and sample
Besides the 16 DCE choice tasks (for the estimation of the decision
model) and questions regarding respondents’ characteristics, an addi-
tional choice task was added to the survey mimicking the real-world
choice (see Fig. 2); this additional choice task was placed in the middle
of the survey (i.e., after the first 8 DCE choice tasks). Adding this stated
choice task mimicking a real-world healthcare decision, we are able to
check whether DCE is capable of predicting the choices in a hypothe-
tical situation representing the real-life choice, which is a minimal re-
quirement for the external validity (i.e., if DCE fails here, the external
validity will fail as well) (Lancsar and Swait, 2014). The information we
presented about the attributes and their levels, was consistent with the
Dutch national flyer and invitation that participants would receive from
their GP to keep information asymmetry between the hypothetical si-
tuation representing the actual decision and the actual decision as small
as possible. (The ten different versions of the questionnaire are avail-
able in Dutch from the authors on request).
Calculation of optimal sample sizes for a DCE is complicated as it
depends on the true values of the unknown parameters in the assumed
discrete choice model (Lancsar and Louviere, 2008). Using the rule of
thumb proposed by Johnson and Orme (Johnson et al., 2003; Orme,
Table 1
Attributes and attribute levels.
Vaccination attributes Levels
Effectiveness (%) 20 - 40 – 60 - 80
Risk of severe side effects (x out of 1,000,000) 1 - 10 - 100
Risk of mild side effects (x out of 10) 1 - 3 - 5
Protection duration (months) 3 - 6 - 12
Vaccine will become active (x weeks after vaccination) 2 – 4
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1998), followed by the sample size calculation approach of De Bekker-
Grob et al. (de Bekker-Grob et al., 2015) after the pilot run of 100 re-
spondents, a minimal sample size of complete data from 300 re-
spondents was required. Assuming a response rate of 30% (Watson
et al., 2017), taking into account a survey completion failure rate of
20%, at least 1250 individuals aged 60 years and older, representative
in terms of age and gender, should be recruited. However, given the
research budget at hand, we strived to simply maximize the sample size
and therefore contacted 1600 individuals aged 60 years and older, re-
presentative in terms of age and gender, for the survey via two Dutch
general practices mentioned earlier. Trying to overpower the study as
much as possible is beneficial for reasons other than statistical precision
(e.g., to facilitate in-depth analysis) (de Bekker-Grob et al., 2015).
As the aim was to investigate whether stated vaccination choice can
predict actual vaccination choice, each invitee received the survey
three weeks before the vaccination invitation letter. This time frame
was chosen to give individuals sufficient time to fill out the
questionnaire, while the impact of the questionnaire on preferences for
the actual choice is limited.
2.4. Field data
Three months after the vaccination invitation letter, field data (i.e.,
actual influenza vaccination data) was collected at an individual level
via the same two Dutch general practices as mentioned above. Field
data among the same invitees who filled out the questionnaire were
collected, which was the only way to test to what extent actual vacci-
nation is consistent with predictions based on stated choices at an in-
dividual level. Noteworthy, in the Netherlands, the general practitioner
sends the invitation letter for influenza vaccination. There are, how-
ever, employers who offer influenza vaccination for their employees as
well. In case a person receives two offers (i.e., one from his/her general
practitioner and one from his/her employer) and decides to receive
vaccination at his/her work, common practice is that this person will
Fig. 1. DCE choice task.
Fig. 2. Choice task mimicking the real-world choice of influenza vaccination.
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inform his/her general practitioner. That is, this person will fill out the
standard influenza vaccination reply card from the general practitioner
(i.e., tick the box ‘I will receive/received my flu vaccination via my
employer’) and send the card back to his/her general practitioner. As a
result, the electronic record from the general practice will show that
this person has been vaccinated.
2.5. In-depth interviews
In-depth semi-structured telephone interviews, based on the
Integrated-change (I-change) model (Fig. 3), (de Vries et al., 2005; de
Vries, 2017) took place with individuals who showed discordance be-
tween stated choices and actual healthcare utilization. The I-change
model combines five scientific theories regarding choice behavior
change (trans-theoretical model (Prochaska and Diclemente, 1986), the
theory of planned behavior (Ajzen, 1991), goal setting theory (Locke
and Latham, 2002, 2006), health belief model (Janz and Becker, 1984),
and social cognitive theory (Bandura, 1986)). When the team used
these theories, insights were obtained about which dimension or di-
mensions (e.g., risk perception, illness of family/friends, GP's support in
the decision-process) could explain the discordance.
2.6. Analysis
To avoid that any missing information (e.g., incomplete DCE data
for one or more respondents or missing respondents' characteristics)
would have biased the prediction results, respondents without missing
values in the survey and vaccination registration were included in the
DCE analyses only. An important starting point in investigating the
external validity of DCEs is to focus on the role of the researcher who
must decide on the model specification. As we focus on analyzing DCE
data and their ability to predict actual healthcare choices, we should
keep in mind that respondents in stated choice studies probably have a
different amount of information about the healthcare interventions they
are evaluating than would likely be the case in revealed preference
data. Therefore to keep the choice context constant, we first determined
how complex the choice model (complexity is here defined as the ca-
pacity to reveal underlying preferences; the more “complex” the model,
the more degrees of freedom and the higher the capacity to include
certain effects; see Step A, Fig. 4) needs to be to predict the ‘single
choice task mimicking the real-world choice’ of influenza vaccination
(see Figs. 2 and 4) via DCE correctly at an aggregate and individual
level. That is, we analyzed the DCE data in a systematic sequence: from
a simpler random-utility-maximization (RUM) model (Model A;
Table 2) to more and more complex RUMmodels (Models B-D; Table 2),
and from a simpler random-regret-minimization (RRM) model (Model
E; Table 2) to more and more complex RRM models (Models F-H;
Table 2).
Based on common practice in health economics (de Bekker-Grob
et al., 2012; Clark et al., 2014; Soekhai et al., 2019), we started with the
homogenous preference, homoscedastic multinomial logit (MNL; Model
A, Table 2) (McFadden, 1974) using RUM as the decision rule:= +U V X i C( , ) ,in in in [Eq. 1]
As shown in Equation (1), the latent utility of an alternative i in a
choice set C (as presented to individual n) is decomposable into two
additively separable parts: (i) a systematic (explainable) component
specified as a function of the attributes of the alternatives V(Xin, β); and
(ii) a random (unexplainable) component εin representing stochastic
variation in choices. The MNL model has three key properties: (i) error
terms are assumed independently and identically distributed and Ex-
treme Value type I across alternatives and decision makers; (ii) inde-
pendence of irrelevant alternatives (IIA), following directly from (i);
and (iii) no un-attributable preference heterogeneity. Such assumptions
may be restrictive in describing human behavior, perhaps compro-
mising the external validity of DCE results. Therefore, we started by
first relaxing the IID assumption (heteroscedastic multinomial logit
(HMNL; Model B, Table 2)) followed by relaxing preference homo-
geneity (with 17 known (reported) subject characteristics (HMNL+;
Model C, Table 2)) and by taking randomness of the alternative specific
constant parameter to account for stochastic preferences (i.e., hetero-
geneity from unknown sources) toward the opting out alternative
(HMNL++; Model D, Table 2). That is, in Model D we aimed to explain
heterogeneity by including subject characteristics and using choice re-
sponses to obtain individual conditional parameters to explain hetero-
geneity regarding the alternative specific constant parameter (i.e., ˆ n).
In this way, we are able to distinguish systematic heterogeneity from
stochastic heterogeneity. Noteworthy, we adopted the terminology
from Hess & Train where scale heterogeneity and preference hetero-
geneity are both sources of correlation that reflect random hetero-
geneity (Hess and Train, 2017). Hence, the following random-utility-
maximization choice processes with scale and/or preference hetero-
geneity and/or random opt-out utility were used (see equations
(2)–(5)): = += + +U opt outU opt in X Z X( )( ) in n inin i n i in1 [Eq. 2]
Fig. 3. I-change model (de Vries et al., 2005; de Vries, 2017).
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where= + +Z
~N(0, )
nn 1 n
n
2 [Eq. 3]= µHEV( )in n [Eq. 4]=µ Zexp( )n 2n [Eq. 5]
The quantity αn is the alternative specific constant for opting out of
vaccination compared to opting into vaccination, Z1 and Z2 are two sets
of subject characteristics, ηn a normally distributed random component
in αn, and HEV is a Heteroscedastic Extreme Value distribution with
scale parameter μn (Bhat, 1995; Salisbury and Feinberg, 2010). To
employ terminology common to discrete choice models, our full spe-
cification is a heteroskedastic error component model (Scarpa et al.,
2005; Brownstone and Train, 1998).
The exact same procedure (see Table 5, models E-H) was followed
for using RRM as decision rule:
= + +=R x x i C1 log(1 exp( ( ))) ,in k i
k C
k i in
a 1
A
, ,
[Eq. 6]
As shown in Equation (6), the latent regret of an alternative i in a
choice set C (as presented to individual n) is the systematic (explain-
able) component specified as a function of the attributes of the alter-
natives and a random component εin. The term+ x xlog(1 exp( ( )))k i, , is the core of equation (6) and it quantifies
the regret that is associated with comparing the focal alternative i with
another alternative k in terms of attribute a. Preference heterogeneity
through observed variables Z n1 is captured by defining = + Z n1 ,
similar to equation (2). The chosen functional form implies that regret
approaches zero when alternative k performs (much) worse than i in
terms of attribute a and that it grows as an approximately linear
function of attribute importance and the difference in performance
between alternatives on the attribute, in case al-ternative i performs
(much) worse than k. This specification of regret follows the formula-
tion of Bliemer et al., 2014, 2017, where represents the ‘hardness’ of
the maximum operator in the definition of regret (set to 1 in most
previous work). Note that Van Cranenburgh et al. (van Cranenburgh
et al., 2015) independently derived the same model using a parameter
that represents 1/ . PythonBiogeme software was used to estimate the
models (Bierlaire, 2016). The estimable pa-rameter and represent
the main and interaction effects for (the approximation of) the slope of
the regret-function for attribute x . Like the RUM approach, the latent
regret of an alternative also has a random (unexplainable) component
εin. This term represents the stochastic portion of regret and is assumed
to be independently and identically distributed (IID) and Extreme Value
Type I across alternatives.
To determine the DCE's ability to predict actual healthcare choices
at an aggregate and individual level, we first determined for the ‘single
choice task mimicking the real-world choice’ which proportion of the
sample opted for influenza vaccination (i.e., the observed hypothetical
influenza vaccination uptake); the same procedure was followed for the
actual healthcare utilization (i.e., the observed actual influenza vacci-
nation uptake). Second, we determined to what extent the predicted
uptake was in agreement with the observed uptake at an aggregate and
at an individual level using probability rules, mean values, and 95%
confidence intervals, while at an individual level for Models D and H
conditional parameter estimates were taken into account as well.
Regarding the latter, using the coefficients of Model D, the software
PythonBiogeme, the conditional parameter approach of Train (2003)
and Revelt & Train (Revelt and Train, 2000), and Excel (Hess (2010)),
we were able to determine the alternative specific constants ( ˆ n) per
individual. These alternative specific constants were added to the da-
taset as a variable, because if individuals have system-atically different
preferences, which are unrelated to observed characteristics, not ad-
dressing this heterogeneity will bias the estimates of the preference
weights. The utility function of Model D (or Model H), incorporating
the alternative specific constants per individual, was used to determine
the utility (or regret) weight for each individual for influenza vacci-
nation in the ‘single choice task mimicking the real-world decision’.
Third, we simulated the probabilities for each individual that s/he
would opt-in for influenza vaccination. Fourth, we summarized the
probabilities for influenza vaccination for respondents who opted for
vaccination in the choice task mimicking the real world. Fifth, we
summarized the probabilities for no vaccination for respondents who
opted-out of influenza vaccination in the choice task mimicking the
real-world decision. Finally, these probability scores were summarized,
divided by the sample size and multiplied by 100 to obtain the per-
centage of correctly predicted choices on an individual level (Hensher
et al., 2015). The rationale for employing probability rules in predicting
choices here is crucial from an econometric point of view (Hensher
et al., 2015). Although in some disciplines, such as marketing, assigning
a probability of 1.0 to the highest probability and zero otherwise are
Fig. 4. Comparing stated preferences with actual healthcare utilization.
Table 2
Systematic choice modelling approach.
Model A B C D E F G H
1 Decision rule
Random Utility Maximization X X X X
Random Regret Minimization X X X X
2 Systematic scale heterogeneity X X X X X X
3 Systematic preference heterogeneity X X X X
4 Random opt-out utility X X
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often seen, this would strictly violate the whole idea of a probabilistic
choice model associated with random utility maximization (or random
regret minimization).
The in-depth semi-structured telephone interviews were recorded
and the data was captured by marking respondents’ answers to ques-
tions that aimed to measure the specific elements of one or more di-
mensions of the I-Change Model (Step B, Fig. 4) on a pre-specified
answer sheet. A relatively high or low presence (or absence) of a di-
mension could indicate the behavioral gaps between stated preferences
and revealed preferences, and as a result the misspecification of the
DCE that restricts the predictive ability of DCE for actual healthcare
utilization.
3. Results
3.1. Respondents
Of the 1600 invited subjects, 499 (31%) filled out the questionnaire
(see Fig. 5). Seventy-six percent (377/499) of the respondents did not
have any missing values in the survey nor in the actual healthcare
utilization data, and were of interest for this study. These respondents
had a mean age of 70 years (SD = 6.6), about 52% were male, and 27%
had a higher educational level (Table 3). Approximately 80% of the
respondents reported that they were in good health, 14% had experi-
enced influenza (symptoms) last year, and 54% of the respondents
mentioned that they had been vaccinated against influenza last year.
The number of respondents with strict preferences against vaccinations
(i.e., always chose the opt-out alternative in all 16 DCE tasks) was 91/
377 (24.1%). The number of respondents with strict preferences for
vaccinations (i.e., never chose the opt-out alternative in any of the 16
DCE tasks) was 169/377 (44.8%). The discordance between stated
choices and actual healthcare utilization - based on the comparison of
the response on the single choice task mimicking the real-world choice
vs. actual receipt of the vaccine was 13% (49/377). There were no
significant differences between respondents who showed or did not
show discordance, except that respondents who showed discordance
were more impacted by family (p = 0.05) and by certain convictions
(p = 0.08) regarding influenza vaccination decision (Table 3).
3.2. DCE results
For all four RUM models, the directions of the significant coefficients
of the vaccination attributes and its 2-way interactions were consistent
with our a priori hypotheses, which implies the theoretical va-lidity of
the models (Table 4). The more complex/sophisticated the model, the
better the model fit. There is a very large difference in model fit between
the models that took preference heterogeneity into account versus the
simpler models. Looking at the RUM model with the best model fit
(Model D; i.e., heteroscedastic in error components model), there is
evidence of scale and preference heterogeneity. Re-garding scale het-
erogeneity, respondents who did not have a chronic disease were more
consistent in their choices (i.e., a positive parameter estimate indicates
greater choice consistency), i.e., they were less affected by random var-
iation in utility than respondents who had a chronic disease (p < 0.01).
The same result was found for respondents who had a more deliberative
decision-making style (p = 0.06). Respondents who were impacted by
family members seemed to be less consistent in their choices than re-
spondents who were not impacted by family members in their choice for
influenza vaccination (p = 0.06). Regarding preference heterogeneity,
14 respondent characteristics were observed that explained the pre-
ference heterogeneity found (p < 0.05): age, gender, education,
household, health literacy, numeracy, decision-making style, health
state, having a chronic disease, general attitude to vaccination, having
been vaccinated last year, experience with side effects of vaccination, the
level of impact by family members, and having visited a hospital for him/
herself in the last month. For RRM models, the attribute coefficients had
the expected signs. The best model fit was also found for the hetero-
scedastic in error components model (Model H) (Table 5). This model,
like Model D, also showed evidence that respondents who did not have a
chronic disease were more consistent in their choices (p < 0.01). Re-
spondents who were impacted by family members or were higher edu-
cated were less consistent in their choices (p = 0.09 and p = 0.05 re-
spectively). Regarding preference heterogeneity, the same respondent
characteristics as Model D were detected that explained the preference
hetero-geneity found (p < 0.05), except for ‘having visited a GP for
him/herself in the last month’. There was no evidence that the family
members, age or hospital visit in the last month explained the preference
heterogeneity found in the RRM model.
Fig. 5. Flow chart of including participants for the quantitative and qualitative phase.
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3.3. Predictive ability of DCE
At an aggregate level the SP choice to opt for influenza vaccination
was correctly predicted (i.e., taking the 95% confidence interval into
account) by DCE models if a RUM model with scale and observed
preference heterogeneity was used (Model C; Table 6) or an RRM model
with scale, preference heterogeneity and a random opt-out utility was
used (Model H; Table 6). For both decision processes (RUM and RRM),
we found that a better model fit did not automatically mean better
prediction. For instance, Model C led to a better prediction at an ag-
gregate level than Model D, although the in-sample model fit of Model
D was significantly better.
At an individual level, the choice for influenza vaccination was
predicted best using a heteroskedastic error component model that took
into account observed preference heterogeneity through subject char-
acteristics and unknown subject characteristics sources that system-
atically affect the preference for opting out: 90.8% and 91.1% of the
individuals’ choices were correctly predicted using a RUM and RRM
decision process respectively (i.e., Model D and Model H). Among all
models, RRM Model H resulted in the highest positive predictive value
(PPV) of 0.96, and RUM Model D resulted in the highest negative
predictive value (NPV) of 0.86.
3.4. Discordance between stated choices and actual healthcare utilization
Thirteen percent (49/377) of the respondents showed discordance,
of which the majority (32 out of 49; 65%) said that they would opt for
influenza vaccination, although they did not opt for influenza vacci-
nation in real-life (Fig. 5). There were no significant differences be-
tween respondents who said ‘yes’ but did not opt for flu vaccination in
real-life and respondents who said ‘no’ but opted for flu vaccination in
real-life, except that respondents who said ‘yes’ but did not opt for flu
vac-cination in real-life had a better health condition (p = 0.04).
In-depth interviews based on 24 interviewees showed that the dis-
cordance was incorrectly labelled for five out of 24 respondents (21%)
(Table 7). That is, i) four respondents made an appointment in the
winter instead of the autumn season since they lost their influenza
vaccination invitation; as a result, they received an influenza vaccina-
tion outside the actual data collection period of this study; and ii) one
respondent confirmed that she did not receive an influenza vaccination,
although the field data (GP registration) showed that she had received
an influenza vaccination. Focusing on the 19 interviewees who con-
firmed their discordance, we found that several dimensions played a
role: attitude, social support, action of planning, barriers, and intention.
That is, most subjects who said that they would opt for influenza
Table 3
Respondents’ characteristics of influenza vaccination survey.
All respondents Respondents without discordance between SP
and RP
Respondents with discordance
between SP and RP
Differencea
N = 377 (%) N = 328 (%) N = 49 (%) p-value
Male 197 52.2 170 51.8 27 55.1 0.67
Age (mean; sd) 70.5 6.6 70.5 6.4 70.7 7.6 0.84
Aged 60–64 years 78 20.7 69 21.0 9 18.4 0.85
Aged 65 years or older 299 79.3 259 79.0 40 81.6
Education 0.42
Low 177 47.0 158 48.2 19 38.8
Medium 97 25.7 82 25.0 15 30.6
High 102 27.1 87 26.5 15 30.6
Household (living alone; yes) 73 19.4 68 20.7 5 10.2 0.12
Health 0.66
Good 300 79.6 259 79.0 41 83.7
Moderate 70 18.6 63 19.2 7 14.3
Bad 7 1.9 6 1.8 1 2.0
Visited GP last month (yes) 105 27.9 91 27.7 14 28.6 0.87
Visited Hospital last month (yes) 97 25.7 80 24.4 17 34.7 0.16
Suffering from any disease (no) 219 58.1 191 58.2 28 57.1 0.88
Influenza (symptoms) last year (yes) 53 14.1 44 13.4 9 18.4 0.38
Vaccinated against influenza last year (yes) 204 54.1 179 54.6 25 51.0 0.65
Impact certain conviction on flu vaccination (yes) 40 10.6 31 9.5 9 18.4 0.08 *
Vaccination experience effectiveness (bad) 68 18.0 57.0 17.4 11 22.4 0.41
Vaccination experience side effects 0.75
None 208 55.2 181 55.2 27 55.1
Mild 63 16.7 60 18.3 8 16.3
Severe 24 6.4 19 5.8 4 8.2
Family impacts influenza decision (yes) 22 5.8 16 4.9 6 12.2 0.05 **
General attitude vaccination 0.16
In favour 167 44.3 151 46.0 16 32.7
Neutral 122 32.4 100 30.5 22 44.9
Against 88 23.3 77 23.5 11 22.4
Health literacy
Average (mean; sd) 2.7 0.4 2.7 0.4 2.6 0.5 0.98
Good health literacy (scored 3 or higher) 108 28.6 97 29.6 11 22.4 0.31
Numeracy
SNS average (mean; sd) 4.2 1.1 4.2 1.1 4.0 1.3 0.30
Objective scores correct (yes) 295 78.2 257 78.4 38 77.6 0.86
Good numeracy (i.e. SNS ≥4 and obj scores correct) 210 55.7 184 56.1 26 53.1 0.75
Decision style
Decision style average (mean; sd) 2.8 0.7 2.8 0.7 2.8 0.6 0.73
Rather deliberative (3<) 75 19.9 67 20.4 8 16.3 0.68
neutral (3) 85 22.5 72.0 22.0 13 26.5
Rather intuitive (< 3) 217 57.6 189.0 57.6 28 57.1
*p < 0.10; **p=<0.05.
a Difference between respondents' characteristics with and without discordance between stated preference (SP) and revealed preference (RP).
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Table 4
DCE RUM-results influenza vaccination survey.
Model A Model B Model C Model D
MNL model HMNL model HMNL model + systematic preference
heterogeneity
HMNL model + systematic preference
heterogeneity + random opt−out utility
Utility Function coeff p-value coeff p-value coeff p-value coeff p-value
Alternative-Specific Constant (ASC)
no vaccination 1.270 < 0.01 *** 0.674 < 0.01 *** 1.070 <0.01 *** 2.060 0.03 **
Attributes (main effects)
effectiveness (per 10%) 0.229 < 0.01 *** 0.112 < 0.01 *** 0.001 0.99 0.118 0.01 ***
serious side effects
1/1.000.000 0.374 0.151 0.060 0.509
10/1.000.000 0.243 <0.01 *** 0.116 < 0.01 *** 0.086 0.37 0.037 0.70
100/1.000.000 −0.617 <0.01 *** −0.267 <0.01 *** −0.146 0.20 −0.546 <0.01 ***
mild side effects
1/10 0.026 −0.001 −0.013 0.064
3/10 0.087 0.22 0.053 0.11 0.112 0.16 0.061 0.42
5/10 −0.113 0.12 −0.053 0.13 −0.099 0.21 −0.125 0.10 *
protection duration
3 mo −0.369 −0.147 −0.088 −0.262
6 mo 0.264 <0.01 *** 0.112 < 0.01 *** 0.130 0.17 0.081 0.41
12 mo 0.105 0.16 0.035 0.32 −0.042 0.76 0.181 0.06 *
waiting time
2 wks −0.045 −0.029 −0.008 0.038
4 wks 0.045 0.38 0.029 0.21 0.008 0.88 −0.038 0.45
Two-way interactions
eff x serious10 −0.216 0.08 * −0.107 0.07 * −0.102 0.42 −0.028 0.82
eff x serious100 −0.021 0.88 0.005 0.94 −0.263 0.08 * −0.265 0.06 *
eff x mild3 −0.480 0.71 −0.505 0.38 −1.190 0.37 −0.719 0.58
eff x mild5 −0.296 0.82 0.016 0.98 0.056 0.97 −0.158 0.90
eff x dur6 −0.345 0.01 *** −0.148 0.02 ** −0.332 0.01 *** −0.236 0.08 *
eff x dur12 0.065 0.63 0.027 0.66 0.260 0.07 * 0.241 0.08 *
eff x wait4 0.021 0.81 −0.009 0.82 −0.039 0.67 −0.027 0.75
Scale heterogeneity
deliberative DM style – 0.338 < 0.01 *** −0.102 0.16 0.231 0.06 *
high education – 0.474 < 0.01 *** 0.053 0.38 −0.135 0.12
impact family – 0.350 0.01 *** −0.387 <0.01 *** −0.451 0.06 *
good health – 0.433 < 0.01 *** −0.024 0.76 0.022 0.80
no disease – 0.230 0.02 ** 0.246 <0.01 *** 0.431 <0.01 ***
Systematic preference heterogeneity
age > 64 yr x constant ‘no vacc' – – −0.392 0.02 ** −0.003 0.99
age > 64 yr x eff – – −0.052 0.05 ** −0.068 0.02 **
attitude for x constant 'no vacc' – – −1.400 <0.01 *** −5.220 <0.01 ***
attitude for x dur6 – – 0.057 0.36 0.061 0.31
attitude for x dur12 – – 0.179 0.02 ** 0.017 0.82
attitude for x eff – – 0.091 <0.01 *** 0.005 0.84
attitude for x serious10 – – −0.032 0.59 −0.082 0.15
attitude for x serious100 – – −0.204 0.01 *** 0.064 0.43
no disease x constant 'no vacc' – – 0.563 <0.01 *** 2.550 <0.01 ***
deliberative DM style x constant 'no vacc' – – 0.922 <0.01 *** 1.300 <0.01 ***
deliberative DM style x eff – – 0.183 <0.01 *** 0.120 <0.01 ***
deliberative DM style x serious10 – – 0.067 0.38 0.070 0.32
deliberative DM style x serious100 – – −0.343 <0.01 *** −0.181 0.19
high education x constant 'no vacc' – – 1.580 <0.01 *** 1.030 0.03 **
high education x eff – – 0.202 <0.01 *** 0.284 <0.01 ***
impact family x constant 'no vacc' – – 1.540 0.01 *** 2.140 0.03 **
impact family x eff – – 0.153 0.04 ** 0.163 0.14
impact family x serious10 – – 0.179 0.28 0.224 0.21
impact family x serious100 – – −0.471 0.04 ** −0.396 0.27
flu symptoms last year x constant 'no vacc' – – −0.454 <0.01 *** 0.360 0.27
good health x ascn – – 0.720 <0.01 *** −1.080 0.03 **
good health x eff – – 0.146 <0.01 *** 0.138 <0.01 ***
last month hosp yes x seriousl0 – – 0.042 0.51 0.036 0.56
last month hosp yes x seriousl00 – – −0.181 0.03 ** −0.177 0.02 **
household alone x eff – – −0.071 <0.01 *** −0.102 <0.01 ***
good health literacy x constant 'no vacc' – – 0.514 <0.01 *** 2.150 <0.01 ***
good health literacy x dur6 – – −0.129 0.05 ** −0.142 0.04 **
good health literacy x dur12 – – −0.014 0.86 −0.019 0.81
good health literacy x serious10 – – −0.074 0.23 −0.098 0.11
good health literacy x serious100 – – 0.199 0.01 *** 0.189 0.02 **
good nummeracy x constant 'no vacc' – – −0.266 <0.01 *** −0.421 0.22
good numeracy x dur6 – – 0.106 0.07 * 0.125 0.04 **
good nummeracy x dur12 – – −0.039 0.57 −0.060 0.38
(continued on next page)
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vaccination, although they did not opt for influenza vaccination in real-
life, were quite worried about influenza vaccination, were willing to
accept the disadvantages of not being vaccinated, were not supported
by the GP to opt for influenza vaccination, lost their invitation for in-
fluenza vaccination, and did not have the intention to be vaccinated in
the future. Most subjects who said that they would not opt for influenza
vaccination, although they opted for influenza vaccination in real-life
showed exactly the opposite: they did not worry about influenza vac-
cination, had a rather positive attitude regarding influenza vaccination,
were supported by the GP to opt for influenza vaccination, made an
appointment immediately after they received the influenza vaccination
invitation, and wanted to be vaccinated in the coming years.
4. Discussion
Our study findings give a high degree of confidence in the results
and the external validity of DCE. When choice models took into account
both scale and preference heterogeneity, at an aggregate level, the
proportion of subjects who opt-in for influenza vaccination was cor-
rectly predicted by the DCE. To be more precise, at an aggregate level,
the SP choice to opt for influenza vaccination was correctly predicted
by a RUM model that took scale and observed preference heterogeneity
into account or using an RRM model that took scale, preference het-
erogeneity and a random opt-out regret into account. At the individual
level, both RUM and RRM models with scale, preference heterogeneity
and a random opt-out utility/regret had the best prediction ability: up
to 91% of individual choices were correctly predicted with a PPV up to
0.96 and NPV up to 0.86. There was 13% discordance between stated
choices and actual healthcare utilization. In-depth interviews showed
that several dimensions played a role in clarifying this discordance:
attitude, social support, action of planning, barriers, and intention.
In a previous DCE study that investigated vaccination uptake
(Lambooij et al., 2015), an accuracy of 80% was found between DCE
predictions and actual healthcare utilization at an individual level. This
is lower than our study finding. According to Lambooij et al. (2015) the
PPV and NPV were 0.85 and 0.26, respectively. Our PPV of 0.96 and
NPV of 0.86 were substantially higher and more promising. Except for a
different target group (hepatitis B vaccination vs. influenza vaccina-
tion), a part of the explanation for this phenomenon might be found in
the DCE modeling. In contrast to Lambooij et al., our study took scale
heterogeneity, observed preference heterogeneity and two-way inter-
actions between the attributes into account, all of which played a sig-
nificant role in improving the PPV and NPV.
Our in-depth interviews with the discordant-subjects showed a gap
between preferences and actions. Although a DCE measures an im-
portant component by focusing on relevant attributes that help people
decide to participate in influenza vaccination, several other factors
played a role in clarifying the discordance between preferences and
actions. For respondents that showed discordance, we detected a re-
lative high (conversely, low) amount of presence (absence) of ‘worries
about influenza vaccination’, ‘positive attitude regarding influenza
vaccination’, ‘sensitivity for GP's opinion’, ‘barriers for making an in-
fluenza vaccination appointment’, and ‘how certain the respondent is in
his/her decision for influenza vaccination in the (near) future’.
Although further research is needed to take these dimensions into ac-
count to empirically test how much the inclusion of these omitted
variables to our model will improve the external validity, we re-
commend that DCE practice should change by doing upfront work that
emphasizes relevant constraints and inhibitors of the focal behavior,
not just what promotes the behavior. For example, presently practice on
selecting attributes for DCEs is mostly about what helps people decide
to participate. Inhibitors may be among the attributes (e.g., injectable
vs oral medication), but it is more likely that inhibitors have to do with
exogenous factors like goals, religion, phobias, and social norms.
Hence, a DCE measures an important part of the health policy model,
but not all.
Our study has several limitations. First, there is the issue of the
generalisability of our results. Although the study had a well-considered
Table 4 (continued)
Model A Model B Model C Model D
MNL model HMNL model HMNL model + systematic preference
heterogeneity
HMNL model + systematic preference
heterogeneity + random opt−out utility
good nummeracy x serious10 – – 0.071 0.21 0.089 0.10 *
good nummeracy x serious100 – – −0.222 <0.01 *** −0.256 <0.01 ***
male x constant 'no vacc' – – 0.342 <0.01 *** 1.350 <0.01 ***
male x mild3 – – −0.007 0.90 −0.027 0.63
male x mild5 – – −0.133 0.03 ** −0.085 0.15
no side effects x constant 'no vacc' – – −0.742 <0.01 *** 1.190 0.01 ***
no side effects x serious10 – – 0.093 0.13 0.129 0.03 **
no side effects x serious 100 – – −0.149 0.05 ** −0.128 0.01 ***
vacc last year x constant 'no vacc' – – −0.759 <0.01 *** −4.800 <0.01 ***
vacc last year x dur6 – – 0.102 0.11 0.085 0.18
vacc last year x dur12 – – 0.215 <0.01 *** 0.171 0.03 **
vacc last year x eff – – 0.186 <0.01 *** 0.148 <0.01 ***
vacc last year x serious10 – – 0.040 0.52 0.039 0.52
vacc last year x serious100 – – −0.278 <0.01 *** −0.084 0.32
flu although being vacc x eff – – −0.063 <0.01 *** −0.026 0.33
flu although being vacc x wait4 – – 0.127 0.04 ** 0.104 0.10 *
Random opt-out utility (s.d. of ASC) – – – 5.020 <0.01 ***
Goodness-of-fit
LL −6182 −6140 −4456 −3232
Number Free Param. 16 21 70 71
AIC 2.055 2.043 1.501 1.095
BIC 2.065 2.056 1.546 1.141
respondents 377 377 377 377
*p < 0.10; **p < 0.05; ***p < 0.01; MNL = Multinomial Logit; HMNL=Heteroscedastic Multinomial Logit; coeff = coefficient; mo = months; wks = weeks;
eff = effectiveness; dur = duration; DM = decision-making; vacc = vaccination; ASC = alternative specific constant; ascn = alternative specific constant opt-out
alternative; s.d. = standard deviation; LL = log-likelihood, AIC = Akaike Information Criterion; BIC=Bayesian Information Criterion.
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Table 5
DCE RRM-results influenza vaccination survey.
Model E Model F Model G Model H
MNL model HMNL model HMNL model + systematic preference
heterogeneity
HMNL model + systematic preference
heterogeneity + random opt-out utility
Utility Function coeff p-value coeff p-value coeff p-value coeff p-value
Alternative-Specific Constant
no vaccination −0.552 <0.01 *** −0.138 0.16 −0.823 <0.01 *** −1.420 <0.01 ***
Attributes (main effects)
effectiveness −0.015 <0.01 *** −0.008 <0.01 *** −0.005 0.01 *** −0.003 0.16
serious side effects
1/1.000.000 −0.310 −0.108 −0.246 −0.351
10/1.000.000 −0.186 <0.01 *** −0.087 <0.01 *** −0.132 0.06 * −0.032 0.62 ***
100/1.000.000 0.496 < 0.01 *** 0.195 <0.01 *** 0.378 <0.01 *** 0.382 < 0.01 ***
mild side effects
1/10 −0.068 −0.012 −0.023 −0.106
3/10 −0.053 0.30 −0.039 0.09 * −0.120 0.05 ** −0.070 0.28
5/10 0.121 0.03 ** 0.051 0.05 ** 0.143 0.11 0.176 0.01 ***
protection duration
3 mo 0.275 0.080 0.299 0.313
6 mo −0.171 <0.01 *** −0.064 0.01 *** −0.159 0.03 ** −0.104 0.12 **
12 mo −0.104 0.07 * −0.015 0.55 −0.140 0.06 * −0.209 <0.01 ***
waiting time
2 wks −0.011 0.021 −0.068 −0.137
4wks 0.011 0.80 −0.021 0.30 0.068 0.16 0.137 < 0.01 ***
Two-way interactions
eff x serious10 0.069 0.57 −0.012 0.82 −0.030 0.79 −0.015 0.89
serious10 x eff 0.069 0.57 0.107 0.05 ** 0.088 0.37 −0.074 0.51
eff x serious100 0.058 0.73 0.243 <0.01 *** 0.223 0.16 0.214 0.17
serious100 x eff −0.141 0.44 −0.328 <0.01 *** −0.046 0.65 0.209 0.03 **
eff x mild3 0.089 0.54 0.085 0.15 0.103 0.38 0.022 0.89
mild3 x eff −0.070 0.59 −0.054 0.31 −0.021 0.81 0.001 0.96
eff x mild5 −0.195 0.28 −0.071 0.28 −0.231 0.15 −0.252 0.18
mild5 x eff 0.175 0.29 0.074 0.17 0.127 0.18 0.154 0.32
eff x dur6 0.154 0.31 0.027 0.65 0.153 0.23 0.128 0.33
dur6 x eff 0.060 0.64 0.065 0.19 0.108 0.28 0.024 0.83
eff x dur12 −0.083 0.61 −0.106 0.11 0.018 0.90 0.028 0.84
dur12 x eff 0.064 0.65 0.066 0.23 −0.063 0.58 −0.077 0.55
eff x wait4 −0.018 0.08 * −0.012 0.79 −0.294 0.01 *** −0.398 <0.01 ***
wait4 x eff 0.136 0.07 * 0.055 0.09 * 0.210 <0.01 *** 0.237 < 0.01 ***
Regret Measure
ξ 2.820 0.07 * 1.430 0.01 *** 100 10
Scale heterogeneity
deliberative decision style – 0.378 <0.01 *** −0.249 <0.01 *** 0.027 0.82
no disease – 0.224 0.02 ** 0.177 <0.01 *** 0.399 < 0.01 ***
higher education – 0.490 <0.01 *** −0.086 0.10 * −0.169 0.05 **
impact family – 0.335 0.01 *** −0.319 <0.01 *** −0.220 0.09 *
good health – 0.490 <0.01 *** −0.184 <0.01 *** −0.030 0.73
Systematic preference heterogeneity
attitude for x constant 'no vacc' – – 1.590 <0.01 *** 3.200 < 0.01 ***
no disease x constant 'no vacc' – – −0.381 <0.01 *** −1.710 <0.01 ***
deliberative DM style x constant 'no vacc' – – −0.580 <0.01 *** −0.901 <0.01 ***
deliberative DM style x eff – – −0.014 <0.01 *** −0.010 <0.01 ***
deliberative DM style x serious10 – – −0.153 0.02 ** −0.093 0.10 *
deliberative DM style x serious100 – – 0.467 <0.01 *** 0.262 0.03 **
high education x constant 'no vacc' – – −1.050 <0.01 *** −0.070 0.80
high education x eff – – −0.015 <0.01 *** −0.017 <0.01 ***
impact family x constant 'no vacc' – – −0.400 <0.01 *** −0.373 0.47
flu symptoms last year x constant 'no vacc' – – 0.333 <0.01 *** −0.001 0.99
last month GP visit x constant 'no vacc' – – −0.103 0.07 * 0.427 0.08 *
good health x constant 'no vacc' – – −0.310 <0.01 *** 0.791 0.01 ***
good health x eff – – −0.009 <0.01 *** −0.008 <0.01 ***
household alone x eff – – 0.004 <0.01 *** 0.004 < 0.01 ***
good health literacy x constant 'no vacc' – – −0.442 <0.01 *** −0.981 <0.01 ***
good health literacy x dur6 – – 0.099 0.06 ** 0.117 0.01 ***
good health literacy x dur12 – – 0.004 0.94 −0.012 0.82
good health literacy x mild3 – – 0.124 0.03 ** 0.097 0.07 *
good health literacy x mild5 – – −0.068 0.23 −0.038 0.47
good health literacy x seriousl0 – – 0.058 0.23 0.076 0.09 *
good health literacy x serious100 – – −0.152 0.03 ** −0.138 0.03 **
good numeracy x constant 'no vacc' – – 0.279 <0.01 *** 0.428 0.06 *
good numeracy x dur6 – – −0.084 0.06 * −0.089 0.03 **
good numeracy x dur12 – – 0.038 0.45 0.055 0.23
(continued on next page)
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and systematic study approach, the results were based on one medical
context only due to practical constraints. Further research is therefore
needed to determine whether our results hold in other medical contexts
as well. Our study design can be used as a guide for future studies.
Second, due to the systematic approach we used starting from common
practice in health economics, other choice models (e.g., latent class
model, mixed logit model) and ensemble analyses were not in-
vestigated. Further research is therefore recommended, although DCE
researchers should be cautious about over-fitting their data (as showed
by our study: a better model fit will not automatically lead to a better
prediction). Third, the respondents' vaccination behaviour might have
impacted their responses during the interviews. That is, these re-
spondents may have ‘defended’ their real behaviour choice (i.e., cog-
nitive discordance). This might have biased the interview results. It
would be helpful in future studies to collect information on the theo-
retical factors of the I-Change model prior to the health behaviour as
Table 5 (continued)
Model E Model F Model G Model H
MNL model HMNL model HMNL model + systematic preference
heterogeneity
HMNL model + systematic preference
heterogeneity + random opt-out utility
good numeracy x serious10 – – −0.051 0.22 −0.063 0.10 *
good numeracy x serious100 – – 0.154 0.01 *** 0.152 0.01 ***
male x constant 'no vacc' – – −0.239 <0.01 *** −0.813 <0.01 ***
male x mild3 – – −0.007 0.88 0.023 0.58
male x mild5 – – 0.153 0.01 *** 0.080 0.08 *
vacc last year x constant 'no vacc' – – 1.140 <0.01 *** 3.350 < 0.01 ***
vacc last yearx dur6 – – −0.085 0.07 * −0.074 0.09 *
vacc last year x dur12 – – −0.160 <0.01 *** −0.108 0.04 **
vacc last year x eff – – −0.006 <0.01 *** −0.007 <0.01 ***
vacc last year x serious10 – – −0.020 0.65 −0.022 0.60
vacc last year x serious100 – – 0.145 0.04 ** 0.034 0.62
flu although being vaccinated x eff – – 0.005 <0.01 *** 0.002 0.30
flu although being vaccinated x wait4 – – −0.107 0.02 ** −0.058 0.19
no side effects x constant 'no vacc' – – 0.565 <0.01 *** −0.525 0.05 **
no side effects x eff – – 0.014 <0.01 *** −0.044 0.99
no side effects x serious10 – – −0.075 0.09 * −0.082 0.05 **
no side effects x serious100 – – 0.135 0.03 ** 0.092 0.12
Random opt-out regret (s.d. of ASC) – – – 3.240 < 0.01 ***
Goodness-of-fit
LL −6144 −6094 −4408 −3267
Number Free Param. 24 29 69 70
AIC 2.045 2.030 1.484 1.106
BIC 2.061 2.049 1.529 1.152
respondents 377 377 377 377
*p < 0.10; **p < 0.05; ***p < 0.01; MNL = Multinomial Logit; HMNL=Heteroscedastic Multinomial Logit; coeff = coefficient; mo = months; wks = weeks;
eff = effectiveness; dur = duration; DM = decision-making; vacc = vaccination; ASC = alternative specific constant; ascn = alternative specific constant opt-out
alternative; s.d. = standard deviation; LL = log-likelihood, AIC = Akaike Information Criterion; BIC=Bayesian Information Criterion.
Table 6
DCE model fit and prediction results on an aggregate and individual level.
Model A Model B Model C Model D Model E Model F Model G Model H
Random Utility Maximization Random Regret Minimization
MNL HMNL HMNL+ HMNL++ MNL HMNL HMNL+ HMNL++
Aggregate level
Observed vaccination uptake based on revealed (RP) data 65.0%
Observed vaccination uptake based on choice task (SP) mimicking the real-world
choice of influenza vaccination
68.4%
Predicted vaccination uptake based on DCE: mean 66.4% 62.1% 66.9% 63.8% 74.4% 63.9% 77.9% 68.5%
lower bound CI 66.4% 61.6% 63.4% 60.9% 74.4% 63.4% 75.1% 65.8%
upper bound CI 66.4% 62.5% 70.4% 66.6% 74.4% 64.5% 80.7% 71.2%
Individual level
Proportion of individuals choices that were correctly predicted at an individual level 56.1% 53.9% 80.0% 90.8% 59.0% 54.5% 79.1% 91.1%
Positive Predictive Value (PPV) 0.66 0.62 0.84 0.93 0.63 0.58 0.81 0.96
Negative Predictive Value (NPV) 0.34 0.37 0.71 0.86 0.38 0.42 0.77 0.80
LogLikelihood −6182 −6140 −4456 −3232 −6144 −6094 −4408 −3267
Degrees of freedom 16 21 70 71 24 29 69 70
AIC 2.055 2.043 1.501 1.095 2.045 2.030 1.484 1.106
BIC 2.065 2.056 1.546 1.141 2.061 2.049 1.529 1.152
Respondents (n) 377
Note: MNL = multinomial model; HMNL = heteroscedastic model; HMNL+ = heteroscedastic model plus systematic preference heterogeneity; HMNL+
+ = Heteroscedastic model plus systematic preference heterogeneity plus random intercept; AIC = Akaike Information Criterion; BIC = Bayesian Information
Criterion.
E.W. de Bekker-Grob, et al. Social Science & Medicine 246 (2020) 112736
11
well. Fourth, although the response rate was a bit higher than a priori
expected, a response rate of 31.2% is still not ideal. As a result there
might be a probable lack of representativeness of the individuals who
responded and completed the survey. Finally, a mere-measurement
effect may exist in our sample as the percentage of respondents (65%)
who actually opt for flu vaccination seemed to be higher (although
within the 95% con-fidence interval range) than current Dutch practice
for the same age group (58%; CI 51%–65%).
In conclusion, our study shows that a DCE does its job of predicting
actual healthcare choices of respondents if at least scale and preference
heterogeneity are taken into account, but that there is a gap between
preferences and actions. DCEs are typically focused on the attributes
and the resulting evaluation of a healthcare intervention. In many
cases, including vaccination programs, there are factors inhibiting in-
dividuals from acting in concordance with their preferences. Follow-up
interviews with patients showed that such inhibitors are often not di-
rectly related to the intervention, as they related to goals, religion,
phobias, and social norms. Doing upfront work that emphasizes con-
straints/inhibitors of the focal behavior, not just what promotes the
behavior, might further improve predictive ability. Further research is
recommended to determine whether our conclusion holds for pre-
dicting healthcare choices of an external sample.
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